Amylyx Pharmaceuticals News

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 16 10:19

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 16, 2023 04:12

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 17, 2023 04:33

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 16, 2023 04:29

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 18, 2023 04:13

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 17, 2023 05:25

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 17, 2023 04:52

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 17, 2023 04:51

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 17, 2023 04:46

Amylyx Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 17, 2023 04:44

Amylyx Pharmaceuticals | 424B4: Prospectus

Oct 8, 2022 04:30

Amylyx Pharmaceuticals | EFFECT: Others

Oct 7, 2022 12:15

Amylyx Pharmaceuticals | 424B4: Prospectus

Jan 11, 2022 05:02

Amylyx Pharmaceuticals | EFFECT: Others

Jan 7, 2022 13:15

Amylyx Pharmaceuticals | 8-A12B: Registration of a class of securities on a national securities exchange

Jan 5, 2022 05:02

Amylyx Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jan 4, 2022 21:34